Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

Clinical trial NCT05250362 · UNKNOWN

Trial details

NCT number: NCT05250362
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2022-03-01
Primary completion: 2025-02-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.